Resources Contact Us Home
Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies

Image Number 12 for United States Patent #7491393.

The present invention relates to the identification of antibodies which are specific to human B7.1 antigen (CD80) and which are capable of inhibiting the binding of B7.1 to a CD28 receptor and which are not capable of inhibiting the binding of B7.1 to a CTLA-4 receptor. Two of these antibodies, 16C10 and 7C10, significantly inhibit the production of IL-2, in spite of the existence of a second activating ligand B7.2 (CD86). Blocking of the primary activation signal between CD28 and B7.1 (CD80) with these antibodies while allowing the unimpaired or coincident interaction of CTLA-4 and B7.1 and/or B7.2 represents a combined antagonistic effect on positive co-stimulation with an agonistic effect on negative signalling. These antibodies may be used as specific immunosuppressants, e.g., for the treatment of autoimmune diseases and to prevent organ transplant rejection.

  Recently Added Patents
Cache memory control device, semiconductor integrated circuit, and cache memory control method
Integrating map-reduce into a distributed relational database
Method and apparatus for linking a web browser link to a promotional offer
Electronic device with embedded antenna
Switching apparatus and controlling method thereof
Image forming apparatus capable of timely starting different image formation mode
Circuit arrangement for a piezo transformer, and method therefor
  Randomly Featured Patents
Solid-state imaging device, method for driving the same, method for manufacturing the same, camera, and method for driving the same
Mobile phone holder
Soup server
Flywheel uninterruptible power source
Method and apparatus for measuring modulation accuracy
Porous moisture-absorbing and desorbing polymer and a method for manufacturing the same
Engine controller and enclosure assembly
Method, device and vehicle utilizing the same
Tape dispenser
Imidazo[1,2-.alpha.]pyrazin-3(7H)-one derivatives bearing a new electron-rich structure